Edition:
United States

Apellis Pharmaceuticals Inc (APLS.OQ)

APLS.OQ on NASDAQ Stock Exchange Global Select Market

17.73USD
7 Dec 2018
Change (% chg)

$-0.26 (-1.45%)
Prev Close
$17.99
Open
$18.00
Day's High
$18.00
Day's Low
$17.19
Volume
96,042
Avg. Vol
102,632
52-wk High
$31.69
52-wk Low
$11.45

Chart for

About

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The... (more)

Overall

No Ratios Available.

Financials

  APLS.OQ Industry Sector
P/E (TTM): -- 31.13 33.63
EPS (TTM): -- -- --
ROI: -- 15.55 15.02
ROE: -- 16.92 16.60

Earnings vs. Estimates